New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view JM Lopez-Novoa, Y Quiros, L Vicente, AI Morales, FJ Lopez-Hernandez Kidney international 79 (1), 33-45, 2011 | 869 | 2011 |
Inflammation and EMT: an alliance towards organ fibrosis and cancer progression JM López‐Novoa, MA Nieto EMBO molecular medicine 1 (6‐7), 303-314, 2009 | 764 | 2009 |
Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease MT Grande, B Sánchez-Laorden, C López-Blau, CA De Frutos, A Boutet, ... Nature medicine 21 (9), 989-997, 2015 | 714 | 2015 |
Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study BM Biccard, TE Madiba, HL Kluyts, DM Munlemvo, FD Madzimbamuto, ... The Lancet 391 (10130), 1589-1598, 2018 | 523 | 2018 |
Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries BJA: British Journal of Anaesthesia 117 (5), 601-609, 2016 | 518 | 2016 |
Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects FJ López-Hernández, JM López-Novoa Cell and tissue research 347, 141-154, 2012 | 381 | 2012 |
Glomerular nephrotoxicity of aminoglycosides C Martinez-Salgado, FJ López-Hernández, JM López-Novoa Toxicology and applied pharmacology 223 (1), 86-98, 2007 | 354 | 2007 |
Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway AI Morales, D Detaille, M Prieto, A Puente, E Briones, M Arévalo, ... Kidney international 77 (10), 861-869, 2010 | 352 | 2010 |
The emerging role of TGF-β superfamily coreceptors in cancer C Bernabeu, JM Lopez-Novoa, M Quintanilla Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1792 (10 …, 2009 | 352 | 2009 |
Fibroblast activation and myofibroblast generation in obstructive nephropathy MT Grande, JM Lopez-Novoa Nature Reviews Nephrology 5 (6), 319-328, 2009 | 317 | 2009 |
Partitioning of major and trace components in PM10–PM2. 5–PM1 at an urban site in Southern Europe N Pérez, J Pey, X Querol, A Alastuey, JM López, M Viana Atmospheric Environment 42 (8), 1677-1691, 2008 | 313 | 2008 |
An integrative overview on the mechanisms underlying the renal tubular cytotoxicity of gentamicin Y Quiros, L Vicente-Vicente, AI Morales, JM López-Novoa, ... Toxicological sciences 119 (2), 245-256, 2011 | 300 | 2011 |
The physiological role of endoglin in the cardiovascular system JM López-Novoa, C Bernabeu American Journal of Physiology-Heart and Circulatory Physiology 299 (4 …, 2010 | 295 | 2010 |
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity PD Sánchez-González, FJ López-Hernández, JM López-Novoa, ... Critical reviews in toxicology 41 (10), 803-821, 2011 | 281 | 2011 |
Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications JM López-Novoa, AB Rodríguez-Peña, A Ortiz, C Martínez-Salgado, ... Journal of translational medicine 9, 1-26, 2011 | 243 | 2011 |
Endoglin regulates nitric oxide‐dependent vasodilatation M Jerkic, JV Rivas‐Elena, M Prieto, R Carrón, F Sanz‐Rodríguez, ... The FASEB Journal 18 (3), 609-611, 2004 | 240 | 2004 |
Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives JM López-Novoa, C Martínez-Salgado, AB Rodríguez-Peña, ... Pharmacology & therapeutics 128 (1), 61-81, 2010 | 237 | 2010 |
CD105 prevents apoptosis in hypoxic endothelial cells C Li, R Issa, P Kumar, IN Hampson, JM Lopez-Novoa, C Bernabeu, ... Journal of cell science 116 (13), 2677-2685, 2003 | 236 | 2003 |
Subcellular targets of cisplatin cytotoxicity: an integrated view SM Sancho-Martínez, L Prieto-García, M Prieto, JM Lopez-Novoa, ... Pharmacology & therapeutics 136 (1), 35-55, 2012 | 207 | 2012 |
Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy MT Grande, F Pérez-Barriocanal, JM López-Novoa Journal of inflammation 7, 1-14, 2010 | 203 | 2010 |